ClearPath Diagnostics


Syracuse, NY


Laboratory Services

With Shore Since

September 2011

INdependent Board Members

Robert DeCresce James Forrest Michael George Kevin Johnson


October 2016

Key Shore Contact

John Hennegan

Download Case Study

In October 2016 Shore announced the sale of ClearPath Diagnostics (“ClearPath”), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company. Together, Shore Capital and ClearPath executed a growth strategy that extended the company’s geographic reach to four states and expanded the service menu to include new cutting-edge tests. The growth was driven by organic initiatives as ClearPath expanded the sales force from one professional to a team of nine highly trained business development experts and implemented LEAN processes that ensured best-in-class turnaround times.

Ready to connect with Shore?